Integrative Systems Approaches Towards Brain Pharmacology and Polypharmacology

Polypharmacology is considered as the future of drug discovery and emerges as the next paradigm of drug discovery. The traditional drug design is primarily based on a “one target-one drug” paradigm. In polypharmacology, drug molecules always interact with multiple targets, and therefore it imposes new challenges in developing and designing new and effective drugs that are less toxic by eliminating the unexpected drug-target interactions. Although still in its infancy, the use of polypharmacology ideas appears to already have a remarkable impact on modern drug development. The current thesis is a detailed study on various pharmacology approaches at systems level to understand polypharmacology in complex brain and neurodegnerative disorders. The research work in this thesis focuses on the design and construction of a dedicated knowledge base for human brain pharmacology. This pharmacology knowledge base, referred to as the Human Brain Pharmacome (HBP) is a unique and comprehensive resource that aggregates data and knowledge around current drug treatments that are available for major brain and neurodegenerative disorders. The HBP knowledge base provides data at a single place for building models and supporting hypotheses. The HBP also incorporates new data obtained from similarity computations over drugs and proteins structures, which was analyzed from various aspects including network pharmacology and application of in-silico computational methods for the discovery of novel multi-target drug candidates. Computational tools and machine learning models were developed to characterize protein targets for their polypharmacological profiles and to distinguish indications specific or target specific drugs from other drugs. Systems pharmacology approaches towards drug property predictions provided a highly enriched compound library that was virtually screened against an array of network pharmacology based derived protein targets by combined docking and molecular dynamics simulation workflows. The developed approaches in this work resulted in the identification of novel multi-target drug candidates that are backed up by existing experimental knowledge, and propose repositioning of existing drugs, that are undergoing further experimental validations

Repositioning of european chemicals groups and changes in innovation management : the case of the french chimical industry

Germany, Great Britain, and Switzerland are usually considered to be the dominant powers in the European chemical industry, since they are associated with companies of international stature such as Bayer, BASF, ICI, Ciba-Geigy and Sandoz. Founded decades ago, these firms have marked the sector dynamics with their strategies regarding academic relations, the importance of patents, diversification within a multidivisional structure, and internationalization. At first sight, France would seem to be a less important player in the European chemical industry. However, today it is ranked second in Europe, just behind Germany, and with a greater annual growth rate, as shown in the table below. The current position of the French chemical industry is a result of two simultaneous factors: a change in the relative activity of sectors, and the repositioning of companies. This paper will examine the strategies used by the four French firms that today are the major players in achieving France's unexpected success: Atofina, the chemicals division of Total-Fina-Elf; Aventis, the company formed by a merger between Hoechst Life Sciences and Rhône-Poulenc; L'Oréal; and Air Liquide. The companies have differing histories with regards to the characteristics of the firm at its creation, the consequences of the oil crisis, and recent mergers and acquisitions.

Electronic sensor technologies in monitoring quality of tea: A review

Tea, after water, is the most frequently consumed beverage in the world. The fermentation of tea leaves has a pivotal role in its quality and is usually monitored using the laboratory analytical instruments and olfactory perception of tea tasters. Developing electronic sensing platforms (ESPs), in terms of an electronic nose (e-nose), electronic tongue (e-tongue), and electronic eye (e-eye) equipped with progressive data processing algorithms, not only can accurately accelerate the consumer-based sensory quality assessment of tea, but also can define new standards for this bioactive product, to meet worldwide market demand. Using the complex data sets from electronic signals integrated with multivariate statistics can, thus, contribute to quality prediction and discrimination. The latest achievements and available solutions, to solve future problems and for easy and accurate real-time analysis of the sensory-chemical properties of tea and its products, are reviewed using bio-mimicking ESPs. These advanced sensing technologies, which measure the aroma, taste, and color profiles and input the data into mathematical classification algorithms, can discriminate different teas based on their price, geographical origins, harvest, fermentation, storage times, quality grades, and adulteration ratio. Although voltammetric and fluorescent sensor arrays are emerging for designing e-tongue systems, potentiometric electrodes are more often employed to monitor the taste profiles of tea. The use of a feature-level fusion strategy can significantly improve the efficiency and accuracy of prediction models, accompanied by the pattern recognition associations between the sensory properties and biochemical profiles of tea

Developing genomic models for cancer prevention and treatment stratification

Malignant tumors remain one of the leading causes of mortality with over 8.2 million deaths worldwide in 2012. Over the last two decades, high-throughput profiling of the human transcriptome has become an essential tool to investigate molecular processes involved in carcinogenesis. In this thesis I explore how gene expression profiling (GEP) can be used in multiple aspects of cancer research, including prevention, patient stratification and subtype discovery. The first part details how GEP could be used to supplement or even replace the current gold standard assay for testing the carcinogenic potential of chemicals. This toxicogenomic approach coupled with a Random Forest algorithm allowed me to build models capable of predicting carcinogenicity with an area under the curve of up to 86.8% and provided valuable insights into the underlying mechanisms that may contribute to cancer development. The second part describes how GEP could be used to stratify heterogeneous populations of lymphoma patients into therapeutically relevant disease sub-classes, with a particular focus on diffuse large B-cell lymphoma (DLBCL). Here, I successfully translated established biomarkers from the Affymetrix platform to the clinically relevant Nanostring nCounter© assay. This translation allowed us to profile custom sets of transcripts from formalin-fixed samples, transforming these biomarkers into clinically relevant diagnostic tools. Finally, I describe my effort to discover tumor samples dependent on altered metabolism driven by oxidative phosphorylation (OxPhos) across multiple tissue types. This work was motivated by previous studies that identified a therapeutically relevant OxPhos sub-type in DLBCL, and by the hypothesis that this stratification might be applicable to other solid tumor types. To that end, I carried out a transcriptomics-based pan-cancer analysis, derived a generalized PanOxPhos gene signature, and identified mTOR as a potential regulator in primary tumor samples. High throughput GEP coupled with statistical machine learning methods represent an important toolbox in modern cancer research. It provides a cost effective and promising new approach for predicting cancer risk associated to chemical exposure, it can reduce the cost of the ever increasing drug development process by identifying therapeutically actionable disease subtypes, and it can increase patients’ survival by matching them with the most effective drugs.2016-12-01T00:00:00

2009 Scholar\u27s Day Program

Scholars\u27 Day was established in 1997 and is a day-long conference devoted to showcasing the wide array of scholarship, research and creative activities occurring on campus. In 2012, a new emphasis on student research lead to a name change to Transformations: A Student Research and Creativity Conference. This event focuses on student research, which is defined as an original investigation or creative activity through the primary efforts of a student or group of students. The work should show problem-solving skills and demonstrate new conceptual outcomes.https://digitalcommons.cortland.edu/transformationsprograms/1019/thumbnail.jp

Pleiotropic and Epistatic Network-Based Discovery: Integrated Networks for Target Gene Discovery

Biological organisms are complex systems that are composed of functional networks of interacting molecules and macro-molecules. Complex phenotypes are the result of orchestrated, hierarchical, heterogeneous collections of expressed genomic variants. However, the effects of these variants are the result of historic selective pressure and current environmental and epigenetic signals, and, as such, their co-occurrence can be seen as genome-wide correlations in a number of different manners. Biomass recalcitrance (i.e., the resistance of plants to degradation or deconstruction, which ultimately enables access to a plant’s sugars) is a complex polygenic phenotype of high importance to biofuels initiatives. This study makes use of data derived from the re-sequenced genomes from over 800 different Populus trichocarpa genotypes in combination with metabolomic and pyMBMS data across this population, as well as co-expression and co-methylation networks in order to better understand the molecular interactions involved in recalcitrance, and identify target genes involved in lignin biosynthesis/degradation. A Lines Of Evidence (LOE) scoring system is developed to integrate the information in the different layers and quantify the number of lines of evidence linking genes to target functions. This new scoring system was applied to quantify the lines of evidence linking genes to lignin-related genes and phenotypes across the network layers, and allowed for the generation of new hypotheses surrounding potential new candidate genes involved in lignin biosynthesis in P. trichocarpa, including various AGAMOUS-LIKE genes. The resulting Genome Wide Association Study networks, integrated with Single Nucleotide Polymorphism (SNP) correlation, co-methylation, and co-expression networks through the LOE scores are proving to be a powerful approach to determine the pleiotropic and epistatic relationships underlying cellular functions and, as such, the molecular basis for complex phenotypes, such as recalcitrance